Videos & Documents
In this video, Ashkan Emadi, MD, PhD, discusses a promising checkpoint inhibitor called indoximod that could leave patients with dramatically lower levels of residual disease than standard chemotherapy...
A devastating diagnosis with deadly ovarian cancer recently brought a woman in her 40s to University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC).
With numerous historical anecdotes indicating that thermal therapy — incorporating heat into cancer-zapping treatments — was used by ancient Egyptians, it’s a fact that the University of Maryland helped steer the therapy in the modern age and continues
When a 51-year-old Washington, D.C.-area detective came to University of Maryland Marlene and Stewart Greenebaum Cancer Center with an advanced case of lymphoma, it was his last hope.